Subscribe
A worldwide window to Cambridge business, innovation and technology
2025 Cambridge deals pass $9.25bn as AstraZeneca and Honeywell step on the gas

2025 Cambridge deals pass $9.25bn as AstraZeneca and Honeywell step on the gas

Major acquisitions and mega-fundraisings, mainly driven by AstraZeneca and Honeywell, have propelled the value of deals involving Cambridge-based life sciences and technology companies to more than $9.25 billion in just shy of 10 months to date in 2025.
Historic triple whammy as £500m investment and global alliances boost Cambridge innovation credentials

Historic triple whammy as £500m investment and global alliances boost Cambridge innovation credentials

A pre-Budget £500m investment by the Treasury allied to fresh alliances for the University with key bodies in Hong Kong and South America have handed Cambridge an historic platform on which to build a new era of global Science & Technology dominance.
Steve Young urges caution to avert an AI disaster of 'DotCom bust' proportions

Steve Young urges caution to avert an AI disaster of 'DotCom bust' proportions

Cambridge technology guru Steve Young has issued a heartfelt warning to AI giants not to overplay their hand and risk repeating the disastrous DotCom crash.
AstraZeneca to create around 3,600 Charlottesville jobs with enhanced $4.5bn investment

AstraZeneca to create around 3,600 Charlottesville jobs with enhanced $4.5bn investment

AstraZeneca's tariff-trampling investment spree in the United States has kicked off in spectacular fashion for the Cambridge headquartered life science company and an under-siege American economy. The company is investing $4.5 billion in a new manufacturing facility in Virginia which is expected to create around 3,600 jobs.
Approaching Halloween but cut-price sale is no trick for Treatt

Approaching Halloween but cut-price sale is no trick for Treatt

Directors of Suffolk-based natural extracts specialist Treatt Plc have agreed a £173.8 million sale to fellow UK company Natara Global after macro headwinds knocked the stuffing out of global markets.
Academia
Sharewatch
Manufacturing
Historic triple whammy as £500m investment and global alliances boost Cambridge innovation credentials
23 Oct 2025 - 12:00
Decade of discovery: Cambridge Science Centre's 10-year partnership with AstraZeneca
22 Oct 2025 - 12:00
UK university spinouts win record investment, Parkwalk and Beauhurst reveal
14 Oct 2025 - 12:00

Business awards

Entries now being accepted

Business directory

Browse our listings of Cambridge companies

The killer 50

The 50 hottest disruptive technology companies

News

Reviving pharma investment and the UK’s Life Sciences edge – An existential question for the UK

Reviving pharma investment and the UK’s Life Sciences edge – An existential question for the UK

Pharmaceutical investment in the United Kingdom is approaching an inflection point, as decades of scientific strength are being undermined by policy instability, writes Ben van der Schaaf, Partner and Robert Albarano, Partner at Arthur D. Little.
2025 Cambridge deals pass $9.25bn as AstraZeneca and Honeywell step on the gas

2025 Cambridge deals pass $9.25bn as AstraZeneca and Honeywell step on the gas

Major acquisitions and mega-fundraisings, mainly driven by AstraZeneca and Honeywell, have propelled the value of deals involving Cambridge-based life sciences and technology companies to more than $9.25 billion in just shy of 10 months to date in 2025.
Businesses look past economic headwinds as M & A market slowly makes a return

Businesses look past economic headwinds as M & A market slowly makes a return

After a sluggish start to 2025, the M & A market is showing signs of life. While Q1 was marked by caution and delay, Q2 brought renewed momentum, signalling that there is more activity to come, writes Helen Brocklebank, deal services partner at leading audit, tax and consulting firm RSM UK.
Historic triple whammy as £500m investment and global alliances boost Cambridge innovation credentials

Historic triple whammy as £500m investment and global alliances boost Cambridge innovation credentials

A pre-Budget £500m investment by the Treasury allied to fresh alliances for the University with key bodies in Hong Kong and South America have handed Cambridge an historic platform on which to build a new era of global Science & Technology dominance.
More news

Tech trail

Cambridge Angels CEO has earned her wings and then some!

Cambridge Angels CEO has earned her wings and then some!

Emmi Nicholl has just been promoted to CEO at Cambridge Angels. Tony Quested posed some key questions.
Immaterial raises $18.2m to scale in US and Europe

Immaterial raises $18.2m to scale in US and Europe

Cambridge Science Park company Immaterial Ltd – an advanced materials and engineering solutions pioneer – has raised $18.2 million scale-up funding. Immaterial is developing a proprietary technology platform suited to a diverse range of industrial applications.
Silver Jubilee and golden returns for Cambridge Capital Group

Silver Jubilee and golden returns for Cambridge Capital Group

When private investor network Cambridge Capital Group officially opened its doors with the advent of the Year 2000 billions of people around the world awoke not knowing whether the much-vaunted Millennium Bug had already wiped out their technology and connectivity assets.
Cyclana Bio raises £5m to boost women's health

Cyclana Bio raises £5m to boost women's health

Cyclana Bio, a Cambridge biotech pioneering tissue-level approaches to women’s health, has closed a £5 million pre-seed funding round, co-led by NfX and Eka VC, and including Cocoa VC, Wilbe, and angel investors.
More Tech trail

Trade floor

Paragraf clinches significant deal in United Arab Emirates

Paragraf clinches significant deal in United Arab Emirates

Graphene-based electronic devices pioneer Paragraf, which is located in Cambridgeshire, has scored a significant success in the United Arab Emirates.
Arm and Meta power next era of AI for billions worldwide

Arm and Meta power next era of AI for billions worldwide

Cambridge headquartered superchip architect Arm has joined forces with Californian US giant Meta to enable richer, more accessible AI experiences for billions of people worldwide across the entire ambit of compute.
Cognidox launches aggressive growth strategy after acquisition by US company

Cognidox launches aggressive growth strategy after acquisition by US company

Cambridge tech company Cognidox has launched ambitious expansion plans after being snapped up for an undisclosed sum by US business Recur Software. The strategy includes hiring fresh tech stars from its local base.
Cambridge-US alliance boosts single cell research

Cambridge-US alliance boosts single cell research

A transatlantic alliance between SPT Labtech in the Cambridge Cluster and Nasdaq-quoted California company 10x Genomics promises major progress in single cell research.
Marshall and Dowty to make Hercules even stronger!

Marshall and Dowty to make Hercules even stronger!

Cambridge's Marshall Aerospace and Dowty, a GE Aerospace company, have concluded a new agreement aiming to provide more effective and streamlined support for global operators of the Lockheed Martin C-130J Super Hercules.
More Trade floor